ARHGEF3 and Duchenne muscular dystrophy: In the current study with an mdx model of DMD, we found evidence that inhibiting ROCK or its upstream activator ARHGEF3 can improve dystrophic muscle function by alleviating the loss of muscle quality, a characteristic feature of DMD observed in several model species.35, 36